webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

Fmoc-Gly-Gly-Phe-OtBu

  CAS No.: 236426-37-2   Cat No.: BADC-01104   Purity: 99.80% 4.5  

Fmoc-Gly-Gly-Phe-OtBu is a protected peptide ADC linker intermediate used for protease-sensitive drug release, enabling site-specific antibody conjugation and improved therapeutic index in ADC development.

Fmoc-Gly-Gly-Phe-OtBu

Structure of 236426-37-2

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C32H35N3O6
Molecular Weight
557.64
Shipping
Room temperature, or blue ice upon request.
Shipping
Store at -20 °C, keep in dry and avoid sunlight.

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
tert-butyl N-[(9H-fluoren-9-ylmethoxy)carbonyl]glycylglycyl-L-phenyl alaninate; tert-butyl (2S)-2-[[2-[[2-(9H-fluoren-9-ylmethoxycarbonylamino)acetyl]amino]acetyl]amino]-3-phenylpropanoate
IUPAC Name
tert-butyl (2S)-2-[[2-[[2-(9H-fluoren-9-ylmethoxycarbonylamino)acetyl]amino]acetyl]amino]-3-phenylpropanoate
Canonical SMILES
CC(C)(C)OC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24
InChI
InChI=1S/C32H35N3O6/c1-32(2,3)41-30(38)27(17-21-11-5-4-6-12-21)35-29(37)19-33-28(36)18-34-31(39)40-20-26-24-15-9-7-13-22(24)23-14-8-10-16-25(23)26/h4-16,26-27H,17-20H2,1-3H3,(H,33,36)(H,34,39)(H,35,37)/t27-/m0/s1
InChIKey
XQLGBXCTOOARCT-MHZLTWQESA-N
Solubility
10 mm in DMSO
Appearance
Solid
Shelf Life
0-4°C for short term (days to weeks), or -20°C for long term (months).
Shipping
Room temperature, or blue ice upon request.
Storage
Store at -20 °C, keep in dry and avoid sunlight.
Form
Solid
Biological Activity
Fmoc-Gly-Gly-Phe-OtBu is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs)[1]

Fmoc-Gly-Gly-Phe-OtBu is a peptide compound commonly used in the field of peptide synthesis. It serves as an important building block in the solid-phase peptide synthesis (SPPS) method, where it is utilized to form longer peptide chains. The Fmoc (9-fluorenylmethyloxycarbonyl) group is particularly useful as a temporary protecting group for the amino terminus of the peptide during synthesis. The Fmoc group is easily removed under mildly basic conditions, which allows for sequential addition of amino acids while minimizing side reactions. This functionality makes Fmoc-Gly-Gly-Phe-OtBu a versatile intermediate for complex peptide assembly.

Additionally, Fmoc-Gly-Gly-Phe-OtBu is employed in the development of bioactive peptides for therapeutic applications. The presence of phenylalanine (Phe) in the sequence provides aromaticity, which is essential for certain receptor interactions or to impart specific structural properties to the resulting peptides. This can be crucial in the development of peptides that target proteins or receptors involved in disease mechanisms. Moreover, the glycine residues (Gly-Gly) may contribute to flexibility in the peptide structure, facilitating its interaction with other biomolecules.

The OtBu (tert-butoxy) group, which protects the carboxyl group during synthesis, is another significant feature of Fmoc-Gly-Gly-Phe-OtBu. This protective group helps maintain stability during the synthesis process and can be removed selectively when needed. The OtBu group also contributes to the compound's overall stability, preventing premature cleavage or reactions that could compromise the integrity of the peptide chain. This makes Fmoc-Gly-Gly-Phe-OtBu an ideal candidate for use in controlled synthesis protocols, where maintaining precise structural integrity is essential.

In addition to its application in peptide synthesis, Fmoc-Gly-Gly-Phe-OtBu is valuable in studies of protein folding and interaction. The specific arrangement of amino acids within this compound can be tailored to mimic certain structural motifs found in proteins, making it a useful tool in structural biology. By incorporating such compounds into experimental models, researchers can gain insights into the principles of peptide folding, stability, and the mechanisms by which peptides interact with their biological targets.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: Fmoc-Gly-Gly-Phe-Gly-CH2-O-CH2-Gly-CH2-O-CH2-Cbz | Fmoc-Gly-Gly-Phe-OtBu
Send Inquiry
Verification code
Inquiry Basket